Orgenesis (ORGS) - Company Total Revenue

Orgenesis Inc. is scaling its business through decentralized cell therapy manufacturing by providing software and equipment to clinics. The company relies on a distributed R&D model, attracting leading biotechnologists. Analyzing corporate sales dynamics on GURU.Markets, we see a strategic shift toward automated IT modules, while 0.00 expresses the metric value today.

Orgenesis Inc. (ORGS) Revenue and Sales Volume: for the period 07/04/2022 - 10/26/2024

Analytical breakdowns for Orgenesis (ORGS)

- current price and projected stock value:

Share Price Orgenesis Corporation|ORGS - Analyst Consensus Forecast

- market capitalization indicators:

Market Value Orgenesis Inc.|ORGS - Total Company Value

- book value of equity indicators:

Net Assets per Share Orgenesis|ORGS - Book Capitalization|Market Capitalization to Book Value orgenesis.com|ORGS - Aggregate Company Assets

- company liabilities and liquidity data:

- earnings and market multiples details:

ORGS - Net Income|Company Profit Forecast Orgenesis Inc.|ORGS - Price to Earnings Ratio|Projected Price to Earnings Ratio orgenesis.com|ORGS - Price/Earnings to Growth Ratio|Business Value to Operating Income Before Depreciation Orgenesis Inc.|ORGS - Operating profit EBITDA|Net earnings per share for the trailing year Orgenesis|ORGS - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months orgenesis.com|ORGS - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Orgenesis Inc.

- company sales and revenue statistics:

ORGS - Company Sales|Company Projected Revenue Volume Orgenesis Corporation|ORGS - Market Cap to Revenue|Forward Price to Sales Orgenesis Inc.

Summary company analysis:Orgenesis Inc.

Sales of Orgenesis Inc. (ORGS) reflect the actual volume of cell product commercialization, transforming operational activity into cash flow. By analyzing the company's sales growth rate, an investor assesses the efficiency of utilizing high-capacity OMPC complexes and filtration systems, which allows for the differentiation of organic business expansion from temporary fluctuations and prevents an overvaluation of the asset.

Analysis of competing companies